Project co-ordinator Dr Annette Byrne recently presented the ANGIOPREDICT initiative to a highly specialist audience at the Angiogenesis Foundation's 10th International M. Judah Folkman Conference: New Frontiers in Therapeutic Development, San Diego USA. Dr Byrne was invited to present at this prestigious event by the Foundation's President and Medical Director William W. Li MD. Following the Angiogenesis Biomarker Session on Day 2 of the meeting, Dr Li personally congratulated Dr Byrne and the Angiopredict team on the novel integrated multi-disciplinary paradigm to be undertaken, commenting that the future of angiogenesis inhibitor biomarker discovery likely lay in such an approach.